Abvc Biopharma (ABVC) Times Interest Earned (2016 - 2025)
Abvc Biopharma (ABVC) has disclosed Times Interest Earned for 12 consecutive years, with -$67.55 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned fell 1977.84% year-over-year to -$67.55, compared with a TTM value of -$17.2 through Dec 2025, down 201.82%, and an annual FY2025 reading of -$17.2, down 201.82% over the prior year.
- Times Interest Earned was -$67.55 for Q4 2025 at Abvc Biopharma, down from -$63.45 in the prior quarter.
- Across five years, Times Interest Earned topped out at $28.18 in Q4 2021 and bottomed at -$357.48 in Q2 2021.
- Average Times Interest Earned over 5 years is -$72.14, with a median of -$18.43 recorded in 2023.
- Peak annual rise in Times Interest Earned hit 167.78% in 2021, while the deepest fall reached 7507.45% in 2021.
- Year by year, Times Interest Earned stood at $28.18 in 2021, then tumbled by 182.69% to -$23.3 in 2022, then skyrocketed by 128.76% to $6.7 in 2023, then crashed by 148.51% to -$3.25 in 2024, then tumbled by 1977.84% to -$67.55 in 2025.
- Business Quant data shows Times Interest Earned for ABVC at -$67.55 in Q4 2025, -$63.45 in Q3 2025, and -$17.73 in Q2 2025.